Mayne Pharma Group Ltd: MYX announces patent lawsuit against Sun Pharmaceutical
Mayne Pharma Group Ltd: Class action settlement
Mayne Pharma Group Ltd: Approval of additional KAPANOL dosages in Switzerland
Mayne Pharma Group Ltd: MYX to present at Jefferies Global Healthcare Conference
Mayne Pharma Group Ltd: Notification of buy-back - MYX
Mayne Pharma Group Ltd: Mayne Pharma Market Update
Mayne Pharma Group Ltd: MYX announces two additional patents for Nextstellis granted
Mayne Pharma Group Ltd: MYX to present at Citizens JMP Life Sciences Conference
Mayne Pharma Group Ltd: Notification of date for release of 1H24 results
Mayne Pharma Group Ltd: Notification of date for release of 1H24 results
Mayne Pharma Group Ltd: Mayne Pharma to present at JP Morgan Healthcare Conference
Mayne Pharma Group Ltd: Change of Director's Interest Notice
Mayne Pharma Group Ltd: Change of Director's Interest Notice
Mayne Pharma Group Ltd: Initial Director's Interest Notice
Mayne Pharma Group Ltd: Mayne Pharma announces change of auditor
Mayne Pharma Group Ltd: Update on US Department of Justice investigation
Mayne Pharma Group Ltd: Chair's Address to Shareholders
Mayne Pharma Group Ltd: Issuance of additional US Patent for NEXTSTELLIS
Mayne Pharma Group Ltd: MYX to present at Jefferies London Healthcare Conference
Mayne Pharma Group Ltd: ASIC consent for resignation of EY as auditor
No Data